Literature DB >> 28433113

Wilson disease: brain pathology.

Aurélia Poujois1, Jacqueline Mikol2, France Woimant3.   

Abstract

In Wilson disease (WD), brain cellular damage is thought to be due to copper deposition. Striatal lesions are the most characteristic lesions found in the brain of patients with neurologic symptoms, as emphasized in the initial reports of S.A.K. Wilson. WD brain lesions can be more diffuse, including in the pons, midbrain, thalamus, dentate nucleus, and, less frequently, corpus callosum and cortex. In rare cases, extensive cortical-subcortical lesions have been reported. Increased cellularity is noted in the lesions due to the proliferation of modified astrocytes named Alzheimer types of glia and specific cells, called Opalski cells, that are characteristic of WD. Although abnormalities in the putamen predominate in patients with dystonic syndrome, clinicopathologic correlations are scarce. Furthermore, the cerebral copper content is not correlated with the severity of the neuropathologic abnormalities or with the neuropsychiatric symptomatology. This fact raises the question of factors other than copper toxicity that may contribute to the pathogenesis of WD neurologic disturbances.
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATP7A; ATP7B; ATPases; CSF; Wilson disease; astrocytes; blood–brain barrier; copper; hepatocerebral degeneration; lenticular nucleus; metal; neuropathology

Mesh:

Substances:

Year:  2017        PMID: 28433113     DOI: 10.1016/B978-0-444-63625-6.00008-2

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  11 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

Review 2.  Challenges in the diagnosis of Wilson disease.

Authors:  Aurélia Poujois; France Woimant
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

4.  Sleep disorders in Wilson disease: a systematic review and meta-analysis.

Authors:  Jinyang Xu; Qingqing Deng; Qingsong Qin; Alexandros N Vgontzas; Maria Basta; Chanyan Xie; Yun Li
Journal:  J Clin Sleep Med       Date:  2020-01-13       Impact factor: 4.062

Review 5.  Sleep Disorders in Wilson's Disease.

Authors:  Valérie Cochen De Cock; France Woimant; Aurélia Poujois
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

6.  Paramagnetic Metal Accumulation in the Deep Gray Matter Nuclei Is Associated With Neurodegeneration in Wilson's Disease.

Authors:  Xiang-Zhen Yuan; Gai-Ying Li; Jia-Lin Chen; Jian-Qi Li; Xiao-Ping Wang
Journal:  Front Neurosci       Date:  2020-09-16       Impact factor: 4.677

Review 7.  Sleep Abnormalities in Wilson's Disease.

Authors:  Valérie Cochen De Cock; Nadège Girardot-Tinant; France Woimant; Aurélia Poujois
Journal:  Curr Treat Options Neurol       Date:  2018-09-27       Impact factor: 3.598

8.  Dystonic Dysarthria in Wilson Disease: Efficacy of Zolpidem.

Authors:  Aurélia Poujois; Michaela Pernon; Jean-Marc Trocello; France Woimant
Journal:  Front Neurol       Date:  2017-10-31       Impact factor: 4.003

9.  A novel deep intronic variant in ATP7B in five unrelated families affected by Wilson disease.

Authors:  France Woimant; Aurelia Poujois; Adrien Bloch; Tabaras Jordi; Jean-Louis Laplanche; Hélène Morel; Corinne Collet
Journal:  Mol Genet Genomic Med       Date:  2020-08-08       Impact factor: 2.183

Review 10.  Copper Toxicity Is Not Just Oxidative Damage: Zinc Systems and Insight from Wilson Disease.

Authors:  R G Barber; Zoey A Grenier; Jason L Burkhead
Journal:  Biomedicines       Date:  2021-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.